Evidence map›Paper›PMID 34204668›Full record

ReviewMolecules (Basel, Switzerland)2021

Polymeric Drug Delivery System Based on Pluronics for Cancer Treatment.

Jialin Yu, Huayu Qiu, Shouchun Yin, Hebin Wang, Yang Li

Open access · goldAbstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
7.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 125 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Novel Ultrasound-Responsive Amyloid Formulation.Pharmaceuticals (Basel, Switzerland) · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Jialin YuCollege of Material, Chemistry and Chemical Engineering, Hangzhou Normal University, Hangzhou 311121, China.
Huayu QiuCollege of Material, Chemistry and Chemical Engineering, Hangzhou Normal University, Hangzhou 311121, China.
Shouchun YinCollege of Material, Chemistry and Chemical Engineering, Hangzhou Normal University, Hangzhou 311121, China.
Hebin WangCollege of Chemical Engineering and Technology, Tianshui Normal University, Tianshui 741099, China.
Yang LiCollege of Material, Chemistry and Chemical Engineering, Hangzhou Normal University, Hangzhou 311121, China.ORCID 0000-0001-8240-0478
Hangzhou Normal University · CNTianshui Normal University · CN

Funding

National Natural Science Foundation of China 51903070, 21971049, 51863018
6 · The paper itself

Abstract

Pluronic polymers (pluronics) are a unique class of synthetic triblock copolymers containing hydrophobic polypropylene oxide (PPO) and hydrophilic polyethylene oxide (PEO) arranged in the PEO-PPO-PEO manner. Due to their excellent biocompatibility and amphiphilic properties, pluronics are an ideal and promising biological material, which is widely used in drug delivery, disease diagnosis, and treatment, among other applications. Through self-assembly or in combination with other materials, pluronics can form nano carriers with different morphologies, representing a kind of multifunctional pharmaceutical excipients. In recent years, the utilization of pluronic-based multi-functional drug carriers in tumor treatment has become widespread, and various responsive drug carriers are designed according to the characteristics of the tumor microenvironment, resulting in major progress in tumor therapy. This review introduces the specific role of pluronic-based polymer drug delivery systems in tumor therapy, focusing on their physical and chemical properties as well as the design aspects of pluronic polymers. Finally, using newer literature reports, this review provides insights into the future potential and challenges posed by different pluronic-based polymer drug delivery systems in tumor therapy.

Indexed as

Drug CarriersDrug Delivery SystemsHumansHydrophobic and Hydrophilic InteractionsNeoplasmsPoloxamerPolyethylene GlycolsPolymersPolypropylenesPropylene GlycolsTumor MicroenvironmentDrug CarriersPEO-PPO-PEOPoloxamerPolyethylene GlycolsPolymersPolypropylenesPropylene Glycolscancer therapydrug delivery systemhydrophilic-lipophilic balancepluronicstimulus-responsive polymer

Identifiers

PMID34204668
PMCPMC8231161
OpenAlexW3169932468

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.